Zoetis México

What Zoetis México does

Zoetis México is the wholly-owned Mexican subsidiary of Zoetis Inc., the global animal health company (NYSE: ZTS) that was spun off from Pfizer in 2013. Headquartered in Cuajimalpa de Morelos, Mexico City, the subsidiary markets and distributes a portfolio of more than 300 product lines spanning pharmaceuticals, vaccines, diagnostic kits, genetic tests, and regenerative medicine devices across eight species: dogs, cats, horses, cattle, swine, poultry, sheep, and goats. The portfolio includes high-profile companion animal brands such as Simparica TRIO, Cytopoint, Librela, Solensia, and Revolution Plus, alongside livestock products such as Draxxin, Bovi-Shield Gold, Poulvac, FluSure XP, Clarifide (genetic testing), and CIDR reproductive inserts. The business model combines direct field sales to veterinarians and livestock producers, distribution through veterinary clinics and producer networks, and a B2B e-commerce storefront at shop.zoetis.mx. Revenue is generated primarily through one-time product sales and transaction-based diagnostics, with the global companion-animal segment representing approximately 68% of parent revenue and production animals 31%.

The company's go-to-market blends enterprise field sales with multi-channel consumer and community marketing, including Instagram and Facebook communities (Zoetis Pets, Ganadería Productiva, Zoetis Vet Team, Porciexpertos, Ganadería en Femenino) targeted at pet owners, veterinarians, and livestock producers. Strategic positioning emphasizes training and partnership, exemplified by a January 2026 agreement with UNAM to support veterinary education in Mexico. Operational maturity is reflected in Great Place to Work 2025 recognition and a dedicated Mexico careers page, while marketing assets include dedicated product microsites for Simparica TRIO, Librela, and Solensia. Specific Mexico-level revenue, headcount (estimated 51-100), and growth metrics are not disclosed in the source data; the consolidated parent reports approximately $9.3 billion in FY2024 revenue and roughly 13,800 global employees, with Mexico representing a fraction of these totals.

Name

Zoetis México

Legal name

Zoetis

Website

https://www2.zoetis.mx

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Zoetis México is the Mexican subsidiary of global animal health company Zoetis Inc. (NYSE: ZTS), marketing and distributing pharmaceuticals, vaccines, diagnostics, and regenerative medicine devices across companion and production animals via field sales, veterinary channels, and B2B e-commerce.

Ownership category

akta.pro rank

Product category

Animal Health Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Veterinary Services (54194)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Antimicrobials & Anti-infectives (HLAMAEAE), Veterinary Vaccines (HLAIAEAH)

Keywords

• Animal health pharmaceuticals
• Veterinary vaccines
• Companion animal parasiticides
• Livestock health products
• Veterinary diagnostics

Headquarters

HQ city

Cuajimalpa de Morelos, Ciudad de México

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceuticals and Biologics: Revenue from medications, vaccines, and biological products for livestock and companion animals across eight species including cattle, swine, poultry, sheep, horses, dogs, and cats.
2. Diagnostics and Genetic Testing: Revenue from diagnostic products, kits, and genetic testing services that complement the pharmaceutical portfolio.
3. Companion Animal Products: Revenue from pet health products including parasiticides (Simparica TRIO, Revolution), anti-inflammatories (Rimadyl), dermatologicals (Cytopoint), and pain management (Librela, Solensia).
4. Livestock Products: Revenue from antibiotics, anti-inflammatories, anti-mastitics, hormones, vaccines, and pre-mixes for cattle, swine, poultry, and sheep production.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels12 records

Core offering

Zoetis México develops, manufactures, and commercializes animal health products including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatologicals, hormonal reproductive products, monoclonal antibody therapeutics, diagnostic kits, point-of-care diagnostic equipment, and regenerative-medicine devices for companion animals (dogs and cats) and production animals (cattle, swine, poultry, sheep, horses). The portfolio exceeds 300 product lines across eight species and five major product categories, sold primarily through veterinarians and direct sales to livestock producers in Mexico.

Product overview

Zoetis México operates as a comprehensive animal health company offering an extensive portfolio of over 300 product lines across eight major species (cattle, small ruminants, swine, poultry, aquaculture, dogs, cats, and horses) and five major product categories: vaccines, parasiticides, antibiotics, medicinal feed supplements, and other pharmaceuticals. The company serves two primary segments: companion animals (pets such as dogs and cats, representing 68% of revenue) and production animals (livestock including cattle, swine, poultry, and sheep, representing 31% of revenue). Key products include Simparica TRIO® (comprehensive parasite protection for dogs), Cytopoint® (monoclonal antibody for canine atopic dermatitis), Librela® (osteoarthritis pain relief for dogs), and Solensia® (osteoarthritis treatment for cats) in the companion animal segment. For production animals, the portfolio includes vaccines like Bovi-Shield® Gold and Poulvac® lines, antibiotics such as Draxxin® and Excede®, hormonal reproductive products including CIDR® inserts and Synovex® implants, and diagnostic kits. The company also offers regenerative medicine devices (Pro-Stride® APS, Restigen® PRP, CenTrate® BMA) for equine lameness management and operates an e-commerce platform (shop.zoetis.mx) for product distribution.

Differentiator

Problem solved

Functional benefit

Brands

• Zoetis Pets: Community for pet owners supporting the health and wellbeing of dogs and cats in Mexico.
• Ganadería Productiva
• Ganadería en Femenino
• Zoetis Vet Team

Products and services

• Simparica TRIO Monthly chewable tablet for dogs that provides combined protection against fleas, ticks, heartworm and intestinal parasites. Sold through veterinary prescription in Mexico.
• Cytopoint Injectable monoclonal antibody that controls pruritus associated with atopic dermatitis in dogs. Administered by veterinarians.
• Librela Injectable monoclonal antibody therapy providing safe and effective pain relief from osteoarthritis in dogs. Prescribed and administered by veterinarians.
• Solensia Monoclonal antibody therapy for cats that reduces osteoarthritis pain and improves quality of life. Administered by veterinarians.
• Apoquel Oral anti-pruritic medication for control of itching associated with allergic and atopic dermatitis in dogs. Dispensed through veterinarians.
• Revolution Plus Topical parasiticide for cats providing protection against fleas, ticks, ear mites, heartworm and intestinal parasites. Sold through veterinary channels.
• Cerenia Anti-nausea injectable medication for the treatment and prevention of vomiting in dogs and cats. Dispensed by veterinarians.
• Vanguard Plus 5/L Combination vaccine for dogs providing protection against multiple canine distemper, adenovirus, parvovirus, parainfluenza and leptospira antigens. Administered by veterinarians.
• Draxxin KP Antibiotic formulation for cattle providing rapid and complete recovery from bovine respiratory disease. Sold through veterinarians and livestock channels.
• FluSure XP Vaccine providing complete protection against swine influenza in pigs. Sold through veterinarians and livestock producers in Mexico.
• Procerta (Poulvac line) Innovative vaccination program for poultry, including Poulvac Procerta HVT-IBD vector vaccine for Marek's disease and infectious bursal disease, deployed via in-ovo administration.
• Clarifide Genetic testing service for cattle that analyzes DNA to improve reproductive efficiency, herd productivity and breeding decisions. Sold to cattle producers through Zoetis Mexico.
• Bovi-Shield Gold FP 5 Combination vaccine for cattle providing protection against bovine viral diarrhea, infectious bovine rhinotracheitis, bovine respiratory syncytial virus and other reproductive/respiratory pathogens.
• Spectramast LC Intramammary antibiotic for the treatment of clinical mastitis in lactating dairy cattle. Administered by dairy producers under veterinary guidance.
• CIDR 1900 Cattle Insert Intravaginal progesterone insert used to synchronize estrus and manage reproduction in cattle. Sold to cattle producers and veterinarians.
• Synovex Choice Hormonal growth-promoting implant used in beef cattle for improved weight gain and feed efficiency. Sold to cattle producers.
• Fostera PRRS Modified-live vaccine for protection against Porcine Reproductive and Respiratory Syndrome virus in pigs. Sold to swine veterinarians and producers.
• Witness PED Rapid diagnostic test for the detection of Porcine Epidemic Diarrhea virus antigen in swine fecal samples. Used by swine veterinarians.
• Pro-Stride APS Veterinary sterile device that processes a horse's own blood to produce an autologous protein solution used for managing lameness and treating osteoarthritis.
• Restigen PRP Veterinary sterile device that concentrates platelets from a horse's own blood (up to 9X recovery) to support tissue healing in orthopedic injuries.
• CenTrate BMA

Quantifiable outcome

• 68% of revenue from companion animals, 31% from production animals (2024)

Named customers5 records

Segments6 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• UNAM (National Autonomous University of Mexico)coreStrategic or Co-development Partner · 20 January 2026Zoetis and UNAM signed an agreement to promote the training and formation of future veterinarians in Mexico. This partnership supports veterinary education and professional development in the country.
• Vacunacion InovominorChannel Partner/ Reseller/ DistributorPartner for poultry vaccination services, accessible at vaccinacioninovo.mx, providing vaccination solutions for the poultry industry.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Vetoquinol: Independent animal health company with companion animal and livestock pharmaceutical portfolios. Competes with Zoetis México in anti-infectives, anti-inflammatories and reproductive products marketed to Mexican veterinarians and producers.
• Elanco Animal Health: Public pure-play animal health company (NYSE: ELAN) with strong livestock and companion animal franchises. Direct competitor to Zoetis México in parasiticides, vaccines, dermatology and pain management products sold through Mexican veterinarians.
• Ceva Santé Animale: Global animal health player (privately held) with poultry, swine and ruminant vaccines plus companion animal therapeutics. Overlaps with Zoetis México in production-animal vaccines and is expanding in Latin American pet care.
• MSD Animal Health: Animal health division of Merck & Co., offering vaccines, antiparasitics, antimicrobials and identification products. Competes head-to-head with Zoetis México in cattle, swine, poultry and companion animal segments across the Mexican market.
• Phibro Animal Health: US-listed diversified animal health and mineral nutrition company (NASDAQ: PAHC). Competes with Zoetis México in livestock pharmaceuticals, anticoccidials, vaccines and nutritional specialty products used by Mexican producers.
• Virbac: France-based animal health company with companion animal and livestock portfolios. Competes with Zoetis México across veterinary parasiticide, dermatology and livestock pharmaceutical categories sold to Mexican veterinarians.
• Boehringer Ingelheim Animal Health: Global #2 in animal health with broad vaccines, parasiticides and therapeutics portfolios across companion and production animals. Directly competes with Zoetis México in livestock vaccines, companion parasiticides and pet biologics across Mexican veterinary channels.

Emerging players

• Dechra Pharmaceuticals: Specialty animal health company (now owned by Ceva) focused on companion animal endocrinology, dermatology and pain management. Comparable to Zoetis México in premium canine and feline therapeutics, including Librela/Solensia category adjacencies.

Regional players

• HIPRA: Spanish animal health specialist with deep focus on livestock and aquaculture vaccines and diagnostics. Comparable to Zoetis México in production-animal vaccines, with strong European roots but growing Latin American commercial reach.
• Bimeda: Privately held global animal health manufacturer with a strong Latin American and Mexican distribution footprint. Competes with Zoetis México in livestock parasiticides, anti-infectives, and reproductive hormones.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xzoetispets.com/latam
• YouTubeyoutube.com/channel/UC5dZbZeaoCxwl9VcyTU3Ilg
• Facebookfacebook.com/profile.php?id=100070516143554
• LinkedInlinkedin.com/company/zoetismx
• Instagraminstagram.com/zoetismexicovets

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zoetis México